US equities |
SPCX $167.21 ▲+5.19% NVDA $237.23 ▲+1.40% MU $1,062.72 ▼-1.13% TSLA $379.15 ▲+2.31% MSFT $525.38 ▲+1.52% INTC $116.54 ▼-2.34% SNDK $1,716.35 ▼-0.21% META $745.89 ▲+2.45%
FinancialContent

Articles published by Autifony Therapeutics Ltd

News headline image
Autifony Announces Exclusive Global License and Collaboration Agreement with Jazz Pharmaceuticals on Two Ion Channel Targets for Neurological Disorders
From Autifony Therapeutics Ltd
Via Business Wire
Tickers JAZZ